171 results
DEFA14A
CHRS
Coherus Biosciences Inc
15 Apr 24
Additional proxy soliciting materials
5:10pm
) Kimberly J. Tzoumakas 2. To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst & Young LLP as our independent registered
S-8
CHRS
Coherus Biosciences Inc
28 Mar 24
Registration of securities for employees
4:04pm
(included in Exhibit 5.1).
Consent of Independent Registered Public Accounting Firm.
Power of Attorney (included in the signature page
S-8
EX-23.2
CHRS
Coherus Biosciences Inc
28 Mar 24
Registration of securities for employees
4:04pm
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement
8-K
EX-2.1
zsijq33 w9rkef
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
lpuequklpsw 8ktfd
9 Jan 24
Results of Operations and Financial Condition
9:41pm
8-K/A
EX-23.1
2dkzpl121 mul7gp
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K/A
EX-99.1
t370g21dqppxmjd
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K
EX-99.1
euttjclg12 ewx
27 Oct 23
Regulation FD Disclosure
4:19pm
424B5
9tchnvbdn8defog
12 Sep 23
Prospectus supplement for primary offering
6:04am
424B3
op3vt8cb5kb68gv72o
26 Jul 23
Prospectus supplement
4:59pm